PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent & Greenwich, Chatham, United Kingdom.\', \'Laboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.\', \'DIOSynVax, University of Cambridge, Cambridge, United Kingdom.\', \'Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.\', \'Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.\', \'Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.\', \'Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.773982
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35330908
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35330908>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35330908>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all